EJC Skin Cancer (Jan 2024)
Tebentafusp effect on the tumoural landscape in metastatic uveal melanoma – a post-mortem study
- C. Beland,
- B. Shum,
- A.-L. Cattin,
- H. Mudhar,
- C. Gerard,
- H. Pallikonda,
- B.J.Y. Tan,
- I. Lobon,
- K. Edmonds,
- C. Lewis,
- E. Carlyle,
- F. Byrne,
- C. Naceur-Lombardelli,
- D. Moore,
- I. Proctor,
- A. Toncheva,
- A. Rowan,
- U. Mahadeva,
- A. Green,
- H. Shaw,
- J. Larkin,
- P. Nathan,
- C. Swanton,
- M. Jamal-Hanjani,
- S. Turajlic
Affiliations
- C. Beland
- Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom; Skin and Renal Unit, Royal Marsden Hospital, London, United Kingdom
- B. Shum
- Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom; Skin and Renal Unit, Royal Marsden Hospital, London, United Kingdom
- A.-L. Cattin
- Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom
- H. Mudhar
- National Specialist Ophthalmic Pathology Service (NSOPS), Department of Histopathology, Royal Hallamshire Hospital, Sheffield, United Kingdom
- C. Gerard
- Precision Oncology Center Oncology department, Lausanne University Hospital CHUV, Lausanne, Switzerland
- H. Pallikonda
- Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom
- B.J.Y. Tan
- Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom
- I. Lobon
- Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom
- K. Edmonds
- Skin and Renal Unit, Royal Marsden Hospital, London, United Kingdom
- C. Lewis
- Skin and Renal Unit, Royal Marsden Hospital, London, United Kingdom
- E. Carlyle
- Skin and Renal Unit, Royal Marsden Hospital, London, United Kingdom
- F. Byrne
- Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom
- C. Naceur-Lombardelli
- University College London Cancer Institute, London, United Kingdom
- D. Moore
- Department of Pathology, University College London Hospitals, London, United Kingdom
- I. Proctor
- Department of Pathology, University College London Hospitals, London, United Kingdom
- A. Toncheva
- University College London Cancer Institute, London, United Kingdom
- A. Rowan
- Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom
- U. Mahadeva
- Department of Cellular Pathology, Guy's & St Thomas' Hospital, London, United Kingdom
- A. Green
- Department of Cellular Pathology, Guy's & St Thomas' Hospital, London, United Kingdom
- H. Shaw
- Mount Vernon Cancer Centre, Northwood, United Kingdom; Department of Medical Oncology, University College London Hospitals, London, United Kingdom
- J. Larkin
- Skin and Renal Unit, Royal Marsden Hospital, London, United Kingdom
- P. Nathan
- Mount Vernon Cancer Centre, Northwood, United Kingdom
- C. Swanton
- Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom; Department of Medical Oncology, University College London Hospitals, London, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom
- M. Jamal-Hanjani
- Department of Medical Oncology, University College London Hospitals, London, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom; Cancer Metastasis Laboratory, University College London Cancer Institute, London, United Kingdom
- S. Turajlic
- Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom; Skin and Renal Unit, Royal Marsden Hospital, London, United Kingdom
- Journal volume & issue
-
Vol. 2
p. 100138
